Macrovesicular steatosis in living related liver donors: correlation of biopsy findings with CT liver attenuation index and body mass index

Clinical Transplantation

Volumn 30, Issue 9, 2016, Pages 1016-1020

  Jehangir, Maham ^a   Nazir, Rashed ^a   Jang, Aisha ^a   Rana, Atif ^a   Rafique, Salman ^a   Dar, Faisal Saud ^a  

^a SHIFA INTERNATIONAL HOSPITAL   (Pakistan)

Author keywords

liver attenuation index; liver biopsy; liver donor

Indexed keywords

IODINATED CONTRAST MEDIUM;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DONOR; FEMALE; HEPATOBILIARY PARAMETERS; HISTOPATHOLOGY; HUMAN; LIVER ATTENUATION INDEX; LIVER BIOPSY; LIVER DISEASE; LIVER DONOR; LIVING DONOR; MACROVESICULAR STEATOSIS; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIATION ATTENUATION; RETROSPECTIVE STUDY;

EID: 84985991705     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12782     Document Type: Article

References (17)

1. Lee SW, Park SH, Kim KW, et al. Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors: comparison of visual grading with liver attenuation index. Radiology. 2007;244:479–485.
2. Park SH, Kim PN, Kim KW, et al. Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology. 2006;239:105–112.
3. Van Ness MM, Diehl AM. Is liver biopsy useful in the evaluation of patients with chronically elevated liver enzymes? Ann Intern Med. 1989;111:473–478.
4. Limanond P, Raman SS, Lassman C, Sayre J, Ghobrial RM. Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology. 2004;230:276–280.
5. Kim DY, Park SH, Lee SS, et al. Contrast-enhanced computed tomography for the diagnosis of fatty liver: prospective study with same-day biopsy used as the reference standard. Euro Radiol. 2010;20:359–366.
6. Siriwardana RC, Chan SC, Chok KS, Lo CM, Fan ST. Effects of donor steatosis on liver biochemistry and significance of body mass index in predicting steatosis. HPB (Oxford). 2012;14:619–624.
7. Low S, Chin MC, Ma S, Heng D, Deurenberg-Yap M. Rationale for redefining obesity in Asians. Ann Acad Med Singapore. 2009;38:66–69.
8. World Health Organization: Western Pacific Region. The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. Geneva: WHO; 2000.
9. Calle E, Thun M, Petrelli J. Current literature: body-mass index and mortality in a prospective cohort of U.S. adults. Nutr Clin Pract. 2000;15:50–51.
10. Hennedige T, Anil G, Madhavan K. Expectations from imaging for pre-transplant evaluation of living donor liver transplantation. World J Radiol. 2014;6:693–707.
11. Curvo-Semedo L, Andrade DR, Ruivo C, Paulino C, Caseiro-Alves F. Diffuse fatty liver disease: from diagnosis to quantification. In: El-Baz AS, Saba L, Suri JS, eds. Abdominal and Thoracic Imaging: An Engineering and Clinical Perspective. New York: Springer Science; 2014:99–122.
12. Kodama Y, Ng CS, Wu TT, et al. Comparison of CT methods for determining the fat content of the liver. AJR Am J Roentgenol. 2007;188:1307–1312.
13. Pickhardt PJ, Park SH, Hahn L, Lee SG, Bae KT, Yu ES. Specificity of unenhanced CT for non-invasive diagnosis of hepatic steatosis: implications for the investigation of the natural history of incidental steatosis. Eur Radiol. 2012;22:1075–1082.
14. Park YS, Park SH, Lee SS, et al. Biopsy-proven nonsteatotic liver in adults: estimation of reference range for difference in attenuation between the liver and the spleen at nonenhanced CT. Radiology. 2011;258:760–766.
15. Iwasaki M, Takada Y, Hayashi M, et al. Noninvasive evaluation of graft steatosis in living donor liver transplantation. Transplantation. 2004;78:1501–1505.
16. Rinella ME, Alonso E, Rao S, et al. Body mass index as a predictor of hepatic steatosis in living liver donors. Liver Transpl. 2001;7:409–414.
17. Peng CJ, Yuan D, Li B, et al. Body mass index evaluating donor hepatic steatosis in living donor liver transplantation. Transplant Proc. 2009;41:3556–3559.